Biohacking News Podcast Por Inception Point AI arte de portada

Biohacking News

Biohacking News

De: Inception Point AI
Escúchala gratis

Biohacking News Tracker: Stay Ahead in the World of Biohacking Welcome to "Biohacking News Tracker," your go-to podcast for the latest updates and breakthroughs in the world of biohacking. From cutting-edge technologies and genetic engineering to personalized health and wellness strategies, we cover it all. Each episode features expert interviews, in-depth analysis, and the most current news in biohacking and human optimization. Join us as we explore the intersection of biology and technology, uncovering innovative ways to enhance human potential. Whether you're a biohacking enthusiast, a tech aficionado, or simply curious about the future of health, "Biohacking News Tracker" offers insightful and actionable information. Subscribe now and stay ahead in the rapidly evolving world of biohacking. For more info https://www.quietperiodplease.com/ This content was created in partnership and with the help of Artificial Intelligence AI.Copyright 2026 Inception Point AI Política y Gobierno
Episodios
  • Biohacking Industry Crisis: Credibility Collapse and the Future of Longevity Science

    Biohacking Industry Crisis: Credibility Collapse and the Future of Longevity Science
    Apr 28 2026
    In the past 48 hours, the biohacking industry is grappling with a severe credibility crisis sparked by revelations of Peter Attia's ties to Jeffrey Epstein, as detailed in a YouTube video by James Welsh on April 26, 2026, which has amassed over 5,600 views.[1] Attia, once a pillar of the longevity movement through his podcast The Drive, book Outlive, and advocacy for healthspan, fasting, VO2 max, and supplements, resigned from CBS on February 23, 2026, amid scandal, intensifying doubts about the sectors blend of science and hype.[1] No new product launches, deals, partnerships, or regulatory changes have surfaced in this period, signaling a stall in momentum.[1] Verified statistics from the past week remain absent for market movements, price shifts, supply chain issues, or consumer behavior changes, though online scrutiny of influencers has surged.[1] Chinese peptide imports, a biohacking staple, nearly doubled to about 328 million dollars in the first nine months of an unspecified recent year, hinting at supply growth but raising quality concerns.[4] This echoes 2023 controversies, like Attias Oura Ring lawsuit over stock options and study influence, underscoring recurring corruption fears over innovation.[1] Biotech giants such as Calico Life Sciences and Unity Biotechnology, funded by billions from Peter Thiel and Jeff Bezos since the 2010s, face eroding trust in unproven therapies like plasma transfusions and epigenetic tests.[1] Industry leaders have stayed silent on responses, potentially forcing a pivot from hype to evidence-based practices.[1] A separate 20-week sleep study tied to Dave Aspreys Beyond Biohacking Conference challenges performance assumptions, while Evolutamente promotes light-based health gains among biohackers.[3][5] Overall, the sector confronts trust erosion without fresh catalysts, contrasting any prior innovation buzz with current introspection.(298 words) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.
    Más Menos
    2 m
  • Biohacking's Credibility Crisis: What Longevity Industry Faces Now

    Biohacking's Credibility Crisis: What Longevity Industry Faces Now
    Apr 27 2026
    In the past 48 hours, the biohacking industry faces a major credibility crisis triggered by the fallout from Peter Attia's Epstein connections, spotlighted in a widely viewed YouTube video by James Welsh on April 26, 2026, which has garnered over 5,600 views and dissected Attia's role in mainstreaming longevity trends.[1] Once a leading voice promoting healthspan, fasting, VO2 max, and supplements through his podcast The Drive and book Outlive, Attia's reputation imploded after resigning from CBS on February 23, 2026, amid scandal, raising doubts about the sectors scientific foundation versus its marketing hype.[1] This event amplifies ongoing scrutiny of biohacking as a commercialization machine, with no new product launches, deals, or partnerships reported in the last 48 hours. Biotech firms like Calico Life Sciences and Unity Biotechnology, backed by billions since the 2010s from investors such as Peter Thiel and Jeff Bezos, continue to symbolize high-stakes anti-aging bets, but consumer trust erodes amid unproven offerings like plasma transfusions and epigenetic age tests.[1] Skincare brands, including Polish Choice's Cellular Youth Longevity Serum and NAD complexes, increasingly co-opt longevity buzzwords for anti-aging claims, blending into wellness without fresh regulatory shifts or supply chain news.[1] No verified statistics emerged this week on market movements, price changes, or consumer behavior shifts, though online discussions of biohacking influencers have exploded in recent years, per the analysis.[1] Compared to prior reporting, this mirrors 2023 controversies like Attia's Oura Ring lawsuit over stock options and alleged study influence, signaling persistent corruption concerns rather than innovation.[1] Industry leaders remain silent on responses, but the scandal may curb aspirational hype, pushing biohacking toward evidence-based reevaluation over quick-fix sales.[1] (298 words) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.
    Más Menos
    2 m
  • Biohacking Market Surges to 67 Billion by 2035: Take Solutions Leads India Expansion

    Biohacking Market Surges to 67 Billion by 2035: Take Solutions Leads India Expansion
    Apr 24 2026
    In the past 48 hours, the biohacking industry shows steady momentum with key expansions and positive market forecasts, though no major disruptions or regulatory shifts emerged. Take Solutions Limited announced on April 17 its entry into India's longevity and anti-aging market via a Regulation 30 filing, planning science-backed nutraceuticals, biohacking products, and digital tools for metabolic health and aging, targeting a global sector valued at 27.61 billion USD in 2025 growing to 67.03 billion USD by 2035.[1] Market data from recent analyses reinforces growth: the biohacking wearable and consumer longevity device market stands at 22.51 billion USD in 2025, projected to hit 63.8 billion USD by 2034 at a 12.1 percent CAGR, with Asia Pacific leading at 14.2 percent CAGR driven by wellness tech in South Korea, Japan, and China.[2] NAD precursor supplements also signal strength, entering 2026 with diversified supply and rising demand from aging demographics and biohacking trends.[6] M and A activity remains robust, with 47 acquisitions worth 8.3 billion USD from January 2024 to April 2026, including Samsung's SleepScore Labs buy and Google's stake in Calico.[2] No new product launches, price changes, or supply chain issues surfaced in the last week, but B2B channels like clinics and corporates now claim 22 percent of device revenue, outpacing direct-to-consumer sales.[2] Compared to prior reporting, this aligns with ongoing acceleration—no sharp consumer behavior shifts noted, unlike earlier surges in AI biosensing adoption. Leaders like Take Solutions respond by blending product innovation with tech for preventive care, positioning against competitors in fast-growing Asia.[1][2] Overall, the industry maintains a bullish trajectory amid maturing enterprise demand. (248 words) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.
    Más Menos
    2 m
adbl_web_anon_alc_button_suppression_c
Todavía no hay opiniones